Insider acquisitions
Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.
Transaction timeline & trade size
Choose a reporting owner, transaction period, and security. Open any point for the filing.
Purchases in this page5
Other acquisitions45
Reporting owners32
SalesNot providedCheck original SEC filings
Nov 1, 2025 – Dec 19, 2025 · Transaction dates · Current page sample
Reported quantity · security units
Navan, Inc. · Class A Common Stock · Purchase (code P) · Non-derivative · Currency not specified
Swipe the chart to see the full date range. Exact records are available in the table below.
3 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition
50 dated transactions in this page sample · 32 reporting owners.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type | Quantity | Price | Reference value | Currency |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Airbnb, Inc.Class A Common Stock | BALOGH ARISTOTLE N (Chief Technology Officer) | Exercise / conversion | 11,488 | 122.41 | 1,406,246.08 | Currency not specified |
| Dec 17, 2025 | HELIOS TECHNOLOGIES, INC.Restricted Stock Units | Schuetz Alexander (Director) | Stock award | 754 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | HELIOS TECHNOLOGIES, INC.Restricted Stock Units | Walsh Ian K. (Director) | Stock award | 708 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Robinson John Edward (Chief Scientific Officer) | Stock award | 65,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Robinson John Edward (Chief Scientific Officer) | Stock award | 320,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Robinson John Edward (Chief Scientific Officer) | Stock award | 50,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Robbins Andrew R (President and CEO · Director) | Stock award | 245,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Robbins Andrew R (President and CEO · Director) | Stock award | 840,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Robbins Andrew R (President and CEO · Director) | Stock award | 185,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Pinnow Cole (Chief Commercial Officer) | Stock award | 65,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Pinnow Cole (Chief Commercial Officer) | Stock award | 214,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Pinnow Cole (Chief Commercial Officer) | Stock award | 50,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Sachs Jessica (Chief Medical Officer) | Stock award | 65,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Sachs Jessica (Chief Medical Officer) | Stock award | 320,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Sachs Jessica (Chief Medical Officer) | Stock award | 50,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Kearns Evan (Chief Legal Officer) | Stock award | 55,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Kearns Evan (Chief Legal Officer) | Stock award | 260,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Kearns Evan (Chief Legal Officer) | Stock award | 40,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Green John L. (Chief Financial Officer) | Stock award | 65,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Green John L. (Chief Financial Officer) | Stock award | 300,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Green John L. (Chief Financial Officer) | Stock award | 50,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Atkore Inc.Common Stock | SCHROCK MICHAEL V (Director) | Stock award | 9.4426 | 0 | 0 | Currency not specified |
| Dec 18, 2025 | BIOCRYST PHARMACEUTICALS INCCommon Stock | Stonehouse Jon P (Chief Executive Officer · Director) | Gift received | 10,000 | 0 | 0 | Currency not specified |
| Dec 18, 2025 | BIOCRYST PHARMACEUTICALS INCCommon Stock | Stonehouse Jon P (Chief Executive Officer · Director) | Gift received | 10,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | BIOCRYST PHARMACEUTICALS INCEmp. Stock Option (Right to Buy) | Gayer Charles K (President and CCO) | Stock award | 986,950 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | BIOCRYST PHARMACEUTICALS INCCommon Stock | Gayer Charles K (President and CCO) | Stock award | 471,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | BIOCRYST PHARMACEUTICALS INCEmp. Stock Option (Right to Buy) | Barnes Alane P (Chief Legal Officer) | Stock award | 255,050 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | BIOCRYST PHARMACEUTICALS INCCommon Stock | Barnes Alane P (Chief Legal Officer) | Stock award | 121,700 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | Navan, Inc.Class A Common Stock | HOROWITZ BENJAMIN A (Director · 10% owner) | Purchase | 240,835 | 14.7 | 3,540,274.5 | Currency not specified |
| Dec 18, 2025 | Navan, Inc.Class A Common Stock | HOROWITZ BENJAMIN A (Director · 10% owner) | Purchase | 103,960 | 13.61 | 1,414,895.6 | Currency not specified |
| Dec 17, 2025 | Navan, Inc.Class A Common Stock | HOROWITZ BENJAMIN A (Director · 10% owner) | Purchase | 347,600 | 12.65 | 4,397,140 | Currency not specified |
| Nov 1, 2025 | HALOZYME THERAPEUTICS, INC.Common Stock | Caudill Cortney (SVP, CHIEF OPERATING OFFICER) | Exercise / conversion | 9,326 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | Roivant Sciences Ltd.Common Shares | Sukhatme Mayukh (President & CIO · Director) | Exercise / conversion | 59,513 | 12.68 | 754,624.84 | Currency not specified |
| Dec 17, 2025 | GALECTIN THERAPEUTICS INCCommon Stock | LEWIS JOEL (President and CEO · Director) | Exercise / conversion | 7,829 | 2.86 | 22,390.94 | Currency not specified |
| Dec 17, 2025 | GALECTIN THERAPEUTICS INCCommon Stock | Jamil Khurram (Chief Medical Officer) | Exercise / conversion | 8,500 | 2.5 | 21,250 | Currency not specified |
| Dec 17, 2025 | GALECTIN THERAPEUTICS INCCommon Stock | Jamil Khurram (Chief Medical Officer) | Exercise / conversion | 6,463 | 2.2 | 14,218.6 | Currency not specified |
| Dec 17, 2025 | GALECTIN THERAPEUTICS INCCommon Stock | Shlevin Harold H. (Director) | Exercise / conversion | 20,000 | 1.98 | 39,600 | Currency not specified |
| Dec 18, 2025 | PRINCIPAL FINANCIAL GROUP INCCommon Stock | STRABLE-SOETHOUT DEANNA D (President and CEO) | Stock award | 8,388 | 37.38 | 313,543.44 | Currency not specified |
| Dec 19, 2025 | UNITED THERAPEUTICS CorpCommon Stock | ROTHBLATT MARTINE A (Chairperson & CEO · Director) | Exercise / conversion | 2,000 | 120.26 | 240,520 | Currency not specified |
| Dec 18, 2025 | UNITED THERAPEUTICS CorpCommon Stock | ROTHBLATT MARTINE A (Chairperson & CEO · Director) | Exercise / conversion | 4,000 | 120.26 | 481,040 | Currency not specified |
| Dec 17, 2025 | UNITED THERAPEUTICS CorpCommon Stock | ROTHBLATT MARTINE A (Chairperson & CEO · Director) | Exercise / conversion | 4,000 | 120.26 | 481,040 | Currency not specified |
| Dec 17, 2025 | HYPERION DEFI, INC.Common Stock, par value $0.0001 | Walters Happy David (Director) | Purchase | 61,930 | 3.022 | 187,152.46 | Currency not specified |
| Dec 19, 2025 | Replimune Group, Inc.Common Stock | Patel Sushil (Chief Executive Officer · Director) | Stock award | 200,000 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | Replimune Group, Inc.Common Stock | Xynos Konstantinos (Chief Medical Officer) | Stock award | 60,000 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | Replimune Group, Inc.Common Stock | Hill Emily Luisa (Chief Financial Officer) | Stock award | 60,000 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | Replimune Group, Inc.Common Stock | Sarchi Christopher (Chief Commercial Officer) | Stock award | 35,000 | 0 | 0 | Currency not specified |
| Dec 19, 2025 | Replimune Group, Inc.Common Stock | Schwendenman Andrew (Chief Accounting Officer) | Stock award | 10,000 | 0 | 0 | Currency not specified |
| Dec 17, 2025 | ELUTIA INC.Class A Common Stock | RAKIN KEVIN (Director · 10% owner) · HighCape Partners QP II, L.P. (10% owner) · HighCape Partners GP II, L.P. (10% owner) · HighCape Partners GP II, LLC (10% owner) | Purchase | 50,000 | 0.5199 | 25,995 | Currency not specified |
| Dec 17, 2025 | PALVELLA THERAPEUTICS, INC.Common Stock | Goin Kathleen (Chief Operating Officer) | Exercise / conversion | 2,148 | 9.08 | 19,503.84 | Currency not specified |
| Dec 17, 2025 | PALVELLA THERAPEUTICS, INC.Common Stock | Goin Kathleen (Chief Operating Officer) | Exercise / conversion | 2,154 | 7.14 | 15,379.56 | Currency not specified |
Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transaction details
Reporting owners, quantities, prices, and source filings.
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | Airbnb, Inc.ABNB · company listings | BALOGH ARISTOTLE NChief Technology Officer | Exercise / conversionClass A Common StockNon-derivative security · Code M | 11,488 | 122.41Value: 1,406,246.08Currency not specified | View ↗ |
| Trade: | HELIOS TECHNOLOGIES, INC.HLIO · company listings | Schuetz AlexanderDirector | Stock awardRestricted Stock UnitsDerivative security · Code A | 754 | 0Value: 0Currency not specified | View ↗ |
| Trade: | HELIOS TECHNOLOGIES, INC.HLIO · company listings | Walsh Ian K.Director | Stock awardRestricted Stock UnitsDerivative security · Code A | 708 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Robinson John EdwardChief Scientific Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 65,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Robinson John EdwardChief Scientific Officer | Stock awardCommon StockNon-derivative security · Code A | 320,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Robinson John EdwardChief Scientific Officer | Stock awardCommon StockNon-derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Robbins Andrew RPresident and CEO · Director | Stock awardStock Option (Right to Buy)Derivative security · Code A | 245,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Robbins Andrew RPresident and CEO · Director | Stock awardCommon StockNon-derivative security · Code A | 840,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Robbins Andrew RPresident and CEO · Director | Stock awardCommon StockNon-derivative security · Code A | 185,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Pinnow ColeChief Commercial Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 65,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Pinnow ColeChief Commercial Officer | Stock awardCommon StockNon-derivative security · Code A | 214,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Pinnow ColeChief Commercial Officer | Stock awardCommon StockNon-derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Sachs JessicaChief Medical Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 65,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Sachs JessicaChief Medical Officer | Stock awardCommon StockNon-derivative security · Code A | 320,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Sachs JessicaChief Medical Officer | Stock awardCommon StockNon-derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Kearns EvanChief Legal Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 55,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Kearns EvanChief Legal Officer | Stock awardCommon StockNon-derivative security · Code A | 260,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Kearns EvanChief Legal Officer | Stock awardCommon StockNon-derivative security · Code A | 40,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Green John L.Chief Financial Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 65,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Green John L.Chief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 300,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cogent Biosciences, Inc.COGT · company listings | Green John L.Chief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Atkore Inc.No current listing · company listings | SCHROCK MICHAEL VDirector | Stock awardCommon StockNon-derivative security · Code A | 9.4426 | 0Value: 0Currency not specified | View ↗ |
| Trade: | BIOCRYST PHARMACEUTICALS INCBCRX · company listings | Stonehouse Jon PChief Executive Officer · Director | Gift receivedCommon StockNon-derivative security · Code G | 10,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | BIOCRYST PHARMACEUTICALS INCBCRX · company listings | Stonehouse Jon PChief Executive Officer · Director | Gift receivedCommon StockNon-derivative security · Code G | 10,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | BIOCRYST PHARMACEUTICALS INCBCRX · company listings | Gayer Charles KPresident and CCO | Stock awardEmp. Stock Option (Right to Buy)Derivative security · Code A | 986,950 | 0Value: 0Currency not specified | View ↗ |
| Trade: | BIOCRYST PHARMACEUTICALS INCBCRX · company listings | Gayer Charles KPresident and CCO | Stock awardCommon StockNon-derivative security · Code A | 471,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | BIOCRYST PHARMACEUTICALS INCBCRX · company listings | Barnes Alane PChief Legal Officer | Stock awardEmp. Stock Option (Right to Buy)Derivative security · Code A | 255,050 | 0Value: 0Currency not specified | View ↗ |
| Trade: | BIOCRYST PHARMACEUTICALS INCBCRX · company listings | Barnes Alane PChief Legal Officer | Stock awardCommon StockNon-derivative security · Code A | 121,700 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Navan, Inc.NAVN · company listings | HOROWITZ BENJAMIN ADirector · 10% owner | PurchaseClass A Common StockNon-derivative security · Code P | 240,835 | 14.7 *Value: 3,540,274.5Currency not specified | View ↗ |
| Trade: | Navan, Inc.NAVN · company listings | HOROWITZ BENJAMIN ADirector · 10% owner | PurchaseClass A Common StockNon-derivative security · Code P | 103,960 | 13.61 *Value: 1,414,895.6Currency not specified | View ↗ |
| Trade: | Navan, Inc.NAVN · company listings | HOROWITZ BENJAMIN ADirector · 10% owner | PurchaseClass A Common StockNon-derivative security · Code P | 347,600 | 12.65 *Value: 4,397,140Currency not specified | View ↗ |
| Trade: | HALOZYME THERAPEUTICS, INC.HALO · company listings | Caudill CortneySVP, CHIEF OPERATING OFFICER | Exercise / conversionCommon StockNon-derivative security · Code M | 9,326 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Roivant Sciences Ltd.ROIV · company listings | Sukhatme MayukhPresident & CIO · Director | Exercise / conversionCommon SharesNon-derivative security · Code M | 59,513 | 12.68Value: 754,624.84Currency not specified | View ↗ |
| Trade: | GALECTIN THERAPEUTICS INCGALT · company listings | LEWIS JOELPresident and CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 7,829 | 2.86Value: 22,390.94Currency not specified | View ↗ |
| Trade: | GALECTIN THERAPEUTICS INCGALT · company listings | Jamil KhurramChief Medical Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 8,500 | 2.5Value: 21,250Currency not specified | View ↗ |
| Trade: | GALECTIN THERAPEUTICS INCGALT · company listings | Jamil KhurramChief Medical Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 6,463 | 2.2Value: 14,218.6Currency not specified | View ↗ |
| Trade: | GALECTIN THERAPEUTICS INCGALT · company listings | Shlevin Harold H.Director | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 1.98Value: 39,600Currency not specified | View ↗ |
| Trade: | PRINCIPAL FINANCIAL GROUP INCPFG · company listings | STRABLE-SOETHOUT DEANNA DPresident and CEO | Stock awardCommon StockNon-derivative security · Code A | 8,388 | 37.38Value: 313,543.44Currency not specified | View ↗ |
| Trade: | UNITED THERAPEUTICS CorpUTHR · company listings | ROTHBLATT MARTINE AChairperson & CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 2,000 | 120.26Value: 240,520Currency not specified | View ↗ |
| Trade: | UNITED THERAPEUTICS CorpUTHR · company listings | ROTHBLATT MARTINE AChairperson & CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 4,000 | 120.26Value: 481,040Currency not specified | View ↗ |
| Trade: | UNITED THERAPEUTICS CorpUTHR · company listings | ROTHBLATT MARTINE AChairperson & CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 4,000 | 120.26Value: 481,040Currency not specified | View ↗ |
| Trade: | HYPERION DEFI, INC.HYPD · company listings | Walters Happy DavidDirector | PurchaseCommon Stock, par value $0.0001Non-derivative security · Code P | 61,930 | 3.022 *Value: 187,152.46Currency not specified | View ↗ |
| Trade: | Replimune Group, Inc.REPL · company listings | Patel SushilChief Executive Officer · Director | Stock awardCommon StockNon-derivative security · Code A | 200,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Replimune Group, Inc.REPL · company listings | Xynos KonstantinosChief Medical Officer | Stock awardCommon StockNon-derivative security · Code A | 60,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Replimune Group, Inc.REPL · company listings | Hill Emily LuisaChief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 60,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Replimune Group, Inc.REPL · company listings | Sarchi ChristopherChief Commercial Officer | Stock awardCommon StockNon-derivative security · Code A | 35,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Replimune Group, Inc.REPL · company listings | Schwendenman AndrewChief Accounting Officer | Stock awardCommon StockNon-derivative security · Code A | 10,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | ELUTIA INC.ELUT · company listings | RAKIN KEVINDirector · 10% owner HighCape Partners QP II, L.P.10% owner HighCape Partners GP II, L.P.10% owner HighCape Partners GP II, LLC10% owner Joint filing · amounts unallocated | PurchaseClass A Common StockNon-derivative security · Code P | 50,000 | 0.5199 *Value: 25,995Currency not specified | View ↗ |
| Trade: | PALVELLA THERAPEUTICS, INC.PVLA · company listings | Goin KathleenChief Operating Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 2,148 | 9.08Value: 19,503.84Currency not specified | View ↗ |
| Trade: | PALVELLA THERAPEUTICS, INC.PVLA · company listings | Goin KathleenChief Operating Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 2,154 | 7.14Value: 15,379.56Currency not specified | View ↗ |
50 transactions on this page. Filing date, newest first.
Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →